ED Toxicology
[ED Toxicology ]
EPTIS factsheet 142475 | Last revision 2024-05-22 | URL: https://www.eptis.bam.de/pts142475 https://www.eptis.bam.de/pts142475
| PT provider | ||||||||||||||||||||||
| PT provider | Weqas Weqas | |||||||||||||||||||||
| Based in | United Kingdom | |||||||||||||||||||||
| Language(s) | ||||||||||||||||||||||
| Remarks | ED Toxicology is available as part of a comprehensive suite of programmes for the Clinical Laboratory to cover all of its basic core tests. These include: Serum Chemistry, Urine Chemistry, ED Toxicology, Lipids, Bilirubin and Serum Indices. Four human serum and whole blood samples are distributed monthly, with a minimum of 48 samples distributed over the year covering a wide range including samples at the clinically important decision points. The samples consist of a panel of 8 linearly related samples where salicylate, paracetamol and ethanol have been added gravimetrically to “off the clot” serum from healthy volunteers tested negative for these analytes. The linear panel are distributed on a number of occasions over that period which are used to assess both laboratory and method performance, including linearity, bias, within and between batch imprecision. Separate samples are available for serum Ethylene glycol and Methanol and for Whole Blood Ethanol. Key Features: - Toxic pathological range covered, cut-off levels where clinical decisions can have serious consequences for the patient. - Liquid human serum samples. Linearly related panel covering the analytical and Toxic pathological range. - Samples assess both laboratory and method performance, including linearity, bias, within and between batch imprecision. - Challenging samples at clinically relevant cut-off concentrations. For more information: https://www.weqas.com/services/eqa/ed-toxicology/ or contact@weqas.com | |||||||||||||||||||||
| Keywords | ||||||||||||||||||||||
| Product groups |
Health care / medical devices
|
|||||||||||||||||||||
| Testing fields |
Medical analysis
|
|||||||||||||||||||||
| Technical details | ||||||||||||||||||||||
|
||||||||||||||||||||||
| Aims of the PT scheme | ||||||||||||||||||||||
| Target group of participants | Laboratory Diagnostic services and Point of Care Testing services | |||||||||||||||||||||
| Linked to specific legislation / standards | Accreditation by UKAS on the basis of ISO/IEC 17025, 17043 and 15195 | |||||||||||||||||||||
| Additional, subsidiary aims | validation of testing methods | |||||||||||||||||||||
| Number of participants | ||||||||||||||||||||||
| Accredited or otherwise reviewed by a 3rd party |
Accredited by UKAS on the basis of ISO/IEC 17043 for part of the parameters |
|||||||||||||||||||||
| Operation is commissioned / requested by | ||||||||||||||||||||||
| Fees and frequency | ||||||||||||||||||||||
| Participation fee | Fee dependent on number of participating sections and proximetry of testing methods | |||||||||||||||||||||
| Regularly operated | Yes (Frequency: Monthly. Samples: 4 x 1.0mL Whole Blood Ethanol 4 x 0.5mL. ) | |||||||||||||||||||||
| Year of first operation | 1968 | |||||||||||||||||||||
| Contact details of the PT provider | ||||||||||||||||||||||
| Provider | Contact person | |||||||||||||||||||||
|
Weqas
Unit 6, Parc Ty Glas CF14 5DU Cardiff United Kingdom Phone: 44 (0) 2920 314750 Fax: Web: http://www.weqas.com http://www.weqas.com |
Laura Lloyd-Lewis
Phone: 44 (0) 29218 32884 Fax: Email: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk |
|||||||||||||||||||||
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.